ARIAD Pharmaceuticals Inc (ARIA.OQ)

ARIA.OQ on NASDAQ Stock Exchange Global Select Market

18.84USD
11:51am EDT
Price Change (% chg)

$0.26 (+1.40%)
Prev Close
$18.58
Open
$18.78
Day's High
$18.94
Day's Low
$18.71
Volume
87,283
Avg. Vol
627,660
52-wk High
$25.39
52-wk Low
$15.35

ARIA.OQ

Chart for ARIA.OQ

About

ARIAD Pharmaceuticals, Inc. (ARIAD) is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients. ARIAD’s first medicine, Iclusig, is approved in the United States for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia... (more)

Overall

Beta: 1.27
Market Cap (Mil.): $3,431.54
Shares Outstanding (Mil.): 184.69
Dividend: --
Yield (%): --

Financials

  ARIA.OQ Industry Sector
P/E (TTM): -- 37.93 37.76
EPS (TTM): -1.35 -- --
ROI: -68.17 19.48 18.76
ROE: -73.93 20.17 19.59
Search Stocks

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks